Institute for International Research

8:00am
Morning Coffee

8:15am
Chairman's Address - CNS conference room
Amir Kalali, MD, Global Scientific Head
QUINTILES

8:30am
Tackling the Regulatory Challenges for CNS Drug Approval
Dr. J. Margaretha Oortgiesen, PhD, RAC, CCRP, Managing Director
CATO RESEARCH

9:15am
Conquering the Challenge: Working with Highly Vulnerable Patients in Emerging Markets
Margaretta Nyilas MD, Director - CNS, Global Medical Science
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC

10:00am
Networking Break

10:30am
Keynote - General Session Room
The Quest for Value is the Future for the Global Pharmaceutical Industry
Ian Morrison, PhD, Healthcare Author & Futurist, Author of
HEALTHCARE IN THE NEW MILLENIUM, VISIONS, VALUES, AND LEADERSHIP

11:30
Transition time to CNS room

11:35
Drug Development and Trial Design for Pain Management to Elicit Early Signals of Pain
David Goldman, MD, Chief, Laboratory of Neurogenetics
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM/NIH
(Invited)

12:15pm
Luncheon for Delegates and Speakers

1:30pm
In-depth Interactive Tutorial
Utilize Adaptive Design to Produce Higher Quality Data with Fewer Patients
Michael Murphy, MD, PhD, Chief Medical Officer & Senior Vice President Drug Development
TORREYPINES THERAPEUTICS

4:00pm
Conference Concludes